Immunogenicity and Efficacy of XBB.1.5 rS Vaccine against the EG.5.1 Variant of SARS-CoV-2 in Syrian Hamsters

In Syrian hamsters, the authors measured the humoral and cellular immune response after immunization with the nanoparticle recombinant Spike protein-based COVID-19 vaccine.